✦ LIBER ✦

Interstitial lung diseases: evaluation of the performance of a computerized analysis system versus observers

✍ Scribed by S. Kido; S. Tamura; H. Nakamura; C. Kuroda

Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 728 KB
Volume: 23
Category: Article
ISSN: 0895-6111
DOI: 10.1016/s0895-6111(99)00003-8

No coin nor oath required. For personal study only.

✦ Synopsis

We have been developing a computerized analysis system to detect interstitial lung abnormalities on chest radiographs. In this study, we evaluated the performance of our computerized analysis system and compared it with that of radiologists. The performance of the computerized analysis system was inferior to the mean performance of the chest radiologists. However, the performance of the computerized analysis system was superior to the mean performance of the residents. From our results, the outputs obtained from the computerized analysis system can be used by radiologists as a ''second opinion'', and this system could be especially useful to obtain quantitative data for follow-up of known interstitial lung diseases.

📜 SIMILAR VOLUMES

SCAR R&D Symposium 2003: Comparing the E

SCAR R&D Symposium 2003: Comparing the Efficacy of 5-MP CRT Versus 3-MP LCD in the Evaluation of Interstitial Lung Disease

✍ Steve Langer; Brian Bartholmai; Ken Fetterly; Scott Harmsen; William Ryan; Brad 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 210 KB

Performance evaluation of the FACSCount

Performance evaluation of the FACSCount system: A dedicated system for clinical cellular analysis

✍ K. Strauss; I. Hannet; S. Engels; A. Shiba; D. M. Ward; S. Ullery; M. G. Jinguji 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

Flow cytometers are instruments that can determine multiparameter data simultaneously and have a great potential in providing unique information about cells. The FACSCount System is designed as the first dedicated flow cytometer for the clinical laboratory. Its current configuration provides CD4, CD

A one-year, phase I/IIa, open-label pilo

A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis–associated active interstitial lung disease

✍ Dinesh Khanna; Rajeev Saggar; Maureen D. Mayes; Fereidoun Abtin; Philip J. Cleme 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

Linear prediction analysis-synthesis sys

Linear prediction analysis-synthesis systems: The evaluation and improvement of their performances on a noisy speech signal

✍ Philippe Garcin 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Beta-carotene in multivitamins and the p

Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers : A meta-analysis and evaluation of national brands

✍ Tawee Tanvetyanon; Gerold Bepler 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views

## Abstract ## BACKGROUND Some studies have suggested that beta‐carotene supplementation may increase the risk of lung cancer, particularly among smokers or former smokers. Beta‐carotene, a provitamin A, is available in multivitamins. In the current study, the authors investigated the risk of lung

Queueing analysis: A foundation of perfo

Queueing analysis: A foundation of performance evaluation, volume 1: Vacation and priority systems, Part 1: by H. Takagi. Elsevier Science Publishers, Amsterdam, The Netherlands, April 1991. ISBN: 0-444-88910-8

✍ Yutaka Takahashi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 68 KB